165 related articles for article (PubMed ID: 19819766)
1. Identification and measurement of isoaspartic acid formation in the complementarity determining region of a fully human monoclonal antibody.
Dick LW; Qiu D; Cheng KC
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3841-9. PubMed ID: 19819766
[TBL] [Abstract][Full Text] [Related]
2. Isomerization in the CDR2 of a monoclonal antibody: Binding analysis and factors that influence the isomerization rate.
Dick LW; Qiu D; Wong RB; Cheng KC
Biotechnol Bioeng; 2010 Feb; 105(3):515-23. PubMed ID: 19806678
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.
Sreedhara A; Cordoba A; Zhu Q; Kwong J; Liu J
Pharm Res; 2012 Jan; 29(1):187-97. PubMed ID: 21809161
[TBL] [Abstract][Full Text] [Related]
4. Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit.
Zhou K; Cao X; Bautista J; Chen Z; Hershey N; Ludwig R; Tao L; Zeng M; Das TK
J Pharm Sci; 2020 Jan; 109(1):422-428. PubMed ID: 31469998
[TBL] [Abstract][Full Text] [Related]
5. Ion-pair reversed-phase high performance liquid chromatography method for the quantification of isoaspartic acid in a monoclonal antibody.
Kern W; Mende R; Denefeld B; Sackewitz M; Chelius D
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 955-956():26-33. PubMed ID: 24631807
[TBL] [Abstract][Full Text] [Related]
6. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
[TBL] [Abstract][Full Text] [Related]
7. Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry.
Valliere-Douglass J; Jones L; Shpektor D; Kodama P; Wallace A; Balland A; Bailey R; Zhang Y
Anal Chem; 2008 May; 80(9):3168-74. PubMed ID: 18355059
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
[TBL] [Abstract][Full Text] [Related]
9. Unequivocal Identification of Aspartic Acid and
Hui JO; Flick T; Loo JA; Campuzano IDG
J Am Soc Mass Spectrom; 2021 Aug; 32(8):1901-1909. PubMed ID: 33390012
[TBL] [Abstract][Full Text] [Related]
10. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
[TBL] [Abstract][Full Text] [Related]
11. Probing deamidation in therapeutic immunoglobulin gamma (IgG1) by 'bottom-up' mass spectrometry with electron transfer dissociation.
Mukherjee R; Adhikary L; Khedkar A; Iyer H
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):879-84. PubMed ID: 20196189
[TBL] [Abstract][Full Text] [Related]
12. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity.
Cacia J; Keck R; Presta LG; Frenz J
Biochemistry; 1996 Feb; 35(6):1897-903. PubMed ID: 8639672
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
[TBL] [Abstract][Full Text] [Related]
14. Identification of Asp isomerization in proteins by ¹⁸O labeling and tandem mass spectrometry.
Zhang J; Katta V
Methods Mol Biol; 2012; 899():365-77. PubMed ID: 22735965
[TBL] [Abstract][Full Text] [Related]
15. Identification of isomerization and racemization of aspartate in the Asp-Asp motifs of a therapeutic protein.
Zhang J; Yip H; Katta V
Anal Biochem; 2011 Mar; 410(2):234-43. PubMed ID: 21130067
[TBL] [Abstract][Full Text] [Related]
16. Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.
Terashima I; Koga A; Nagai H
Anal Biochem; 2007 Sep; 368(1):49-60. PubMed ID: 17617368
[TBL] [Abstract][Full Text] [Related]
17. HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region.
Boyd D; Kaschak T; Yan B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(13-14):955-60. PubMed ID: 21440514
[TBL] [Abstract][Full Text] [Related]
18. Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.
Yan Y; Wei H; Fu Y; Jusuf S; Zeng M; Ludwig R; Krystek SR; Chen G; Tao L; Das TK
Anal Chem; 2016 Feb; 88(4):2041-50. PubMed ID: 26824491
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody.
Vlasak J; Bussat MC; Wang S; Wagner-Rousset E; Schaefer M; Klinguer-Hamour C; Kirchmeier M; Corvaïa N; Ionescu R; Beck A
Anal Biochem; 2009 Sep; 392(2):145-54. PubMed ID: 19497295
[TBL] [Abstract][Full Text] [Related]
20. 18O labeling method for identification and quantification of succinimide in proteins.
Xiao G; Bondarenko PV; Jacob J; Chu GC; Chelius D
Anal Chem; 2007 Apr; 79(7):2714-21. PubMed ID: 17313184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
